ErbB3

ErbB3

ErbB3 분자 정보

Molecule Name
Receptor tyrosine-protein kinase erbB-3
분자 별명
ERBB3,HER3,LCCS2,MDA-BF-1,MGC88033,c-erbB3,erbB3-S,p180-ErbB3,p45-sErbB3,p85-sErbB3
Drug Development Progress
임상 약물 수31
시판 약물 수2
최고 연구 개발 단계Approved
표적 별명
EC:2.7.10.1,FERLK,EC 2.7.10,Proto-oncogene-like protein c-ErbB-3,HER3,ERBB3,Erb-B2 Receptor Tyrosine Kinase 3,V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 3,Tyrosine Kinase-Type Cell Surface Receptor HER3,Human Epidermal Growth Factor Receptor 3,Lethal Congenital Contracture Syndrome 2,Receptor Tyrosine-Protein Kinase ErbB-3,EC 2.7.10.1,P180-ErbB3,P45-SErbB3,P85-SErbB3,MDA-BF-1,C-ErbB-3,C-ErbB3,ErbB3-S,ErbB-3,LCCS2,Receptor, ErbB-3
분자 배경
ErbB3,also known as Her3 (human epidermal growth factor receptor 3), is a member of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases. This membrane-bound glycoprotein has a neuregulin binding domain but has not an active kinase domain. It therefore can bind the ligand but cannot mediate the intracellular signal transduction through protein phosphorylation. However, it does form heterodimers with ErbB2 or other EGFR members responsible for tyrosine phosphorylation to give a receptor complex and initiate the related pathway, which lead to cell proliferation or differentiation. Overexpression of this protein has been reported in numerous cancers, including prostate, bladder, and breast tumors. This protein has different isoforms derived from alternative splicing variants, and among which, the secreted isoform lacking the intermembrane region modulates the activity of membrane-bound form.

ErbB3 제품 목록

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
IzalontamabSI-B001; SI-1X6.4Phase 3 ClinicalSichuan Baili Pharmaceutical Co Ltd
Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Colorectal Neoplasms; Digestive System Neoplasms; Esophageal Squamous Cell Carcinoma; Head and Neck Neoplasms; Neoplasms, Glandular and Epithelial; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms
상세
JSKN-016JSKN-016; JSKN016Phase 3 ClinicalJiangsu Alphamab Biopharmaceuticals Co Ltd
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Gastroesophageal Junction Neoplasms; Metastatic breast cancer; Neoplasms; Solid tumours; Stomach Neoplasms; Triple Negative Breast Neoplasms
상세
YL-202YL-202; BNT326Phase 3 ClinicalMediLink Therapeutics Co Ltd
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Uterine Cervical Neoplasms
상세
SHR-A2009SHR-A2009Phase 3 ClinicalSuzhou Suncadia Biopharmaceuticals Co Ltd
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Metastatic breast cancer; Solid tumours; Triple Negative Breast Neoplasms
상세
Patritumab DeruxtecanU3-1402; U3-1402a; MK-1022Phase 3 ClinicalDaiichi Sankyo Co Ltd
Brain metastases; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Lung Neoplasms; Melanoma; Metastatic breast cancer; Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Solid tumours; Stomach Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms
상세
NezutatugHMBD-001Phase 2 ClinicalHummingbird Bioscience
Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Melanoma; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms
상세
SapitinibAZD-8931Phase 2 ClinicalAstrazeneca Plc
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Esophageal Neoplasms; Metastatic breast cancer; Neoplasm Metastasis; Neoplasms; Solid tumours; Stomach Neoplasms
상세
Allitinib TosylateAST-6; ALS-1306; AST-1306Phase 2 ClinicalShanghai Allist Pharmaceutical Technology Co Ltd
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung
상세
HMBD-501ENV-501; HMBD-501; ENV-ONC-501Phase 2 ClinicalHummingbird Bioscience
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Skin Melanoma
상세
JS-212JS212; JS-212Phase 2 ClinicalShanghai Junshi Biosciences Co Ltd
Colorectal Neoplasms; Esophageal Squamous Cell Carcinoma; Lung Neoplasms; Solid tumours
상세
DB-1418AVZO-1418; DB-1418Phase 2 ClinicalDuality Biologics (Suzhou) Co Ltd
Lung Neoplasms; Neoplasms, Glandular and Epithelial; Solid tumours
상세
89Zr-Patritumab deruxtecanPhase 2 ClinicalDaiichi Sankyo Co Ltd, Daiichi Sankyo Inc, The Netherlands Cancer Institute
Carcinoma, Non-Small-Cell Lung
상세
IBI-133IBI133; IBI-133Phase 2 Clinical
Solid tumours
상세
DB-1310DB-1310Phase 2 ClinicalDuality Biologics (Shanghai) Co Ltd, Duality Biologics (Suzhou) Co Ltd
Neoplasm Metastasis; Solid tumours
상세
SIBP-03SIBP-03Phase 2 ClinicalShanghai Institute of Biological Products Co Ltd
Neoplasms; Squamous Cell Carcinoma of Head and Neck
상세
JK-07 (SalubrisBio)JK07; SAL007; SAL-007Phase 2 ClinicalSalubris Biotherapeutics Inc
Heart Failure; Heart Failure, Diastolic; Heart Failure, Systolic; Pulmonary Arterial Hypertension
상세
Recombinat humanized HER3-targeting antibodyPhase 2 ClinicalShanghai Institute of Biological Products Co Ltd
Solid tumours; Squamous Cell Carcinoma of Head and Neck
상세
ElgemtumabNOV-6; LJM-716Phase 1 ClinicalMorphosys Ag, Novartis Pharma Ag
Breast Neoplasms; Esophageal Squamous Cell Carcinoma; Head and Neck Neoplasms; Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms
상세
MP-0274DARPin-41; SPA-28; CME-114; CME-115; CME-118; CME-119; MP-0274Phase 1 ClinicalMolecular Partners Ag
Neoplasms
상세
AV-203AV-203; CAN-017Phase 1 ClinicalAveo
Neoplasms; Solid tumours
상세
HDM-2024HDM2024; HDM-2024Phase 1 ClinicalHangzhou Zhongmei Huadong Pharmaceutical Co Ltd
Solid tumours
상세
KHN-922KHN-922Phase 1 ClinicalChengdu Kanghong Pharmaceutical Group Co Ltd
Neoplasms; Solid tumours
상세
Sirotinib MaleateXZP-5491Phase 1 ClinicalShandong Xuanzhu Pharmaceutical Technology Co Ltd
Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Stomach Neoplasms
상세
PM1300PM-1300; PM1300Phase 1 Clinical
Neoplasms
상세
AK-138-D-1AK138D1; AK-138-D-1Phase 1 Clinical
Neoplasms; Solid tumours
상세
BL-B16D1BLB16D1; BL-B16D1Phase 1 ClinicalBaili-Bio (Chengdu) Pharmaceutical Co Ltd, Sichuan Baili Pharmaceutical Co Ltd
Breast Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck
상세
SYS-6023SYS-6023; SYS6023Phase 1 ClinicalJushi Biopharmaceutical Co Ltd
Breast Neoplasms; Metastatic breast cancer; Solid tumours
상세
AMT-562AMT-562Phase 1 ClinicalMultitude Therapeutics Inc
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Solid tumours; Stomach Neoplasms
상세
SIBP-A13SIBP-A13Phase 1 ClinicalShanghai Institute of Biological Products Co Ltd
Carcinoma, Non-Small-Cell Lung; Head and Neck Neoplasms; Metastatic breast cancer; Solid tumours
상세
Recombinant human ErbB3 fragment vaccine (Zensun)rhErbB3-fPhase 1 ClinicalZensun (Shanghai) Sci&Tech Co Ltd
Neoplasms
상세
DM-002DM-002; DM002 (Danma)Phase 1 ClinicalDanma (Suzhou) Biomedical Technology Co Ltd
Colorectal Neoplasms; Endometrial Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms; Solid tumours
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
Osimertinib MesylateAZD-9291; RDL94R2A16; AZD-9291 Mesylate; AZD9291ApprovedAstrazeneca Plc泰瑞沙, TagrissoUnited StatesCarcinoma, Non-Small-Cell LungAstrazeneca Pharmaceutical Co Ltd2015-11-13
Adenocarcinoma; Adenocarcinoma of Lung; Brain metastases; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Colonic Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Glioblastoma; Glioma; Head and Neck Neoplasms; Hematologic Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphoma; Melanoma; Meningeal Neoplasms; Multiple Myeloma; Neoplasm, Residual; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Rectal Neoplasms; Skin Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Thyroid Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms
상세
ZenocutuzumabMCLA-128ApprovedMerus NvBizengriUnited StatesPancreatic Neoplasms; Carcinoma, Non-Small-Cell LungMerus Nv2024-12-04
Carcinoma, Non-Small-Cell Lung; Metastatic breast cancer; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Solid tumours
상세